Long-acting therapeutics

AGILE COVID-19 drug testing platform opens new trial in South Africa

October 7, 2021

Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C

September 21, 2021

New Unilever Radiochemistry Research Fellow

May 25, 2021

The Nanotherapeutics Hub joins iiCON

May 18, 2021

Long-acting injectable medicine as potential route to COVID-19 therapy

April 14, 2021

Two new therapies to be tested in ground-breaking COVID-19 clinical trial

January 12, 2021

Liverpool launches new Centre of Excellence for Long-acting Therapeutics

Study highlights risks associated with the sequential infection of influenza followed by COVID-19

October 15, 2020

£2.2m for Liverpool-led initiative to rapidly identify COVID-19 ‘game changing’ drugs

June 19, 2020

University scientists receive free support to ensure ‘timely dissemination’ of COVID-19 research findings

April 27, 2020